Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Micron Technology, Inc. (MU) vs Koninklijke Philips NV (PHG) Price & Performance

Micron Technology, Inc.Trade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Micron Technology, Inc. vs Koninklijke Philips NV — how do they compare? Micron Technology, Inc. trades at $1,040.33 (market cap $1.17T), while Koninklijke Philips NV trades at $24.39 (market cap $23.52B). The key difference: Micron Technology, Inc. is far larger — about 49.7× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Micron Technology, Inc. for 48 Days and Koninklijke Philips NV for 84 Days on average.

MUPHG
Market Cap
$1.17T$23.52B
Volume
29,425,9061,635,069
Sector
TechnologyHealth
52-Week High
$1.21K$32.91
52-Week Low
$181.60$23.81
Typical Hold Time
48 Days84 Days
Enterprise Value
$1.13T$29.87B
Dividend Yield
0.06%4.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Micron Technology, Inc.

Micron Technology (MU) trades at $1,088, up 4.06% with strong bullish momentum, supported by consecutive earnings beats and robust AI-driven memory demand. The stock shows impressive fundamentals with 63.8% net margins and 91.77% ROE, while technical indicators signal bullish moving averages. Recent strategic customer agreements covering 35% of revenue through 2030 provide visibility, though growth deceleration concerns linger.

Outlook remains positive with analyst consensus at $1,590 price target (82.85% buy ratings), but risks include cyclical memory pricing, competitive pressures, and potential AI demand normalization. The stock's valuation appears reasonable with P/E of 13.94, supporting continued upside if execution persists.

Koninklijke Philips NV

PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.

PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MU
38% Buy62% Sell
Avg holding period · 48 Days
PHG

No sentiment data available yet.

Top news

Latest headlines on both assets

About Micron Technology, Inc.

Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.

Read more on MU →

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG →